Completed OBSERVATIONAL NCT07267091
The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study
Sponsor: PeriPharm
Conditions
Lupus Lupus Arthritis Lupus Arthritis, Systemic Lupus Erythematosus Quality of Life (QOL)
Interventions
No Intervention: Observational Cohort
Updated 2 times since 2026 Last updated: Jan 27, 2026 Started: Nov 3, 2025 Primary completion: Jan 23, 2026 Completion: Jan 23, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07267091, this observational or N/A phase trial focuses on Lupus and Lupus Arthritis and remains completed. Sponsored by PeriPharm, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Jan 2026 — Feb 2026 [monthly]
Enrolling By Invitation
First recorded
Nov 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- PeriPharm
Data source: PeriPharm
For direct contact, visit the study record on ClinicalTrials.gov .